How well a Parkinson's treatment works in real-world care

This study is observing how well Foslevodopa/Foscarbidopa works for people with advanced Parkinson's disease in everyday clinical practice across Belgium. The medication is given as a continuous injection under the skin and is already approved for treating Parkinson's. Researchers want to understand how effective this treatment is when used in real hospital and clinic settings, rather than in a controlled research environment.

Advanced Parkinson's disease is challenging to treat, and doctors need better information about how well available treatments actually work for patients in regular care. This study will help fill that gap by collecting real-world evidence about how this medication helps people manage their symptoms over time.